| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |